Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gleason

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
ACS Applied Materials & Interfaces|June 23, 2012
Combination of iCVD and porous silicon for the development of a controlled drug delivery systemSteven J P McInnes, Endre J Szili, Sameer A Al-Bataineh, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 15, 2015
Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive CoatingSteven J P McInnes, Endre J Szili, Sameer A Al-Bataineh, et al.
Molecular Cancer Therapeutics|October 19, 2012
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine productionMichelle K Gleason, Michael R Verneris, Deborah A Todhunter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2013
Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibitionAndres Wiernik, Bree Foley, Bin Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 12, 2013
25th anniversary article: CVD polymers: a new paradigm for surface modification and device fabricationAnna Maria Coclite, Rachel M Howden, David C Borrelli, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|January 22, 2015
Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addictionT A Ignatowski, R Aalinkeel, J L Reynolds, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistChristine E Brotherton-Pleiss, Michael P Dillon, Anthony P D W Ford, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 15, 2010
Chemical vapor deposition of conformal, functional, and responsive polymer filmsMahriah E Alf, Ayse Asatekin, Miles C Barr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2014
An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomesJulie A Ross, Jakub Tolar, Logan G Spector, et al.
Blood|February 11, 2012
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Michelle K Gleason, Todd R Lenvik, Valarie McCullar, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
ACS Applied Materials & Interfaces|June 23, 2012
Combination of iCVD and porous silicon for the development of a controlled drug delivery systemSteven J P McInnes, Endre J Szili, Sameer A Al-Bataineh, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 15, 2015
Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive CoatingSteven J P McInnes, Endre J Szili, Sameer A Al-Bataineh, et al.
Molecular Cancer Therapeutics|October 19, 2012
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine productionMichelle K Gleason, Michael R Verneris, Deborah A Todhunter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2013
Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibitionAndres Wiernik, Bree Foley, Bin Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 12, 2013
25th anniversary article: CVD polymers: a new paradigm for surface modification and device fabricationAnna Maria Coclite, Rachel M Howden, David C Borrelli, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|January 22, 2015
Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addictionT A Ignatowski, R Aalinkeel, J L Reynolds, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistChristine E Brotherton-Pleiss, Michael P Dillon, Anthony P D W Ford, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 15, 2010
Chemical vapor deposition of conformal, functional, and responsive polymer filmsMahriah E Alf, Ayse Asatekin, Miles C Barr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2014
An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomesJulie A Ross, Jakub Tolar, Logan G Spector, et al.
Blood|February 11, 2012
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Michelle K Gleason, Todd R Lenvik, Valarie McCullar, et al.
Pageof 15